Therefore, pro-inflammatory cytokines, released in the inflammatory milieu of developing MS lesions could enhance the synthesis and release of BDNF in the periphery, thus explaining the association of hallmarks of aggressive MS with sBDNF, but not cBDNF. The gene discussed is BDNF; the disease is myeloid sarcoma.